The Virus Filtration Market is estimated to be valued at US$ 5.08 Bn in 2023 and is expected to exhibit a CAGR of 14.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Virus filtration is a crucial step in bioprocessing that helps remove viruses from biological samples such as biotherapeutics, vaccines, and other injectables. Virus filters utilize size exclusion technology that physically separates viruses by size from the sample fluid passing through virus-retaining membrane. Key applications of virus filtration include removal of adventitious viruses from biologics, vaccines, cell banking, and other injectable products.
Market Dynamics:
The Global Virus Filtration Market Size is primarily driven by the rapid growth of the biopharmaceutical industry. Rising demand for monoclonal antibodies and recombinant proteins along with increasing outsourcing of biologics production to contract manufacturing organizations is expected to boost the virus filtration system demand over the forecast period. Moreover, continuous technological advancements in virus filtration systems such as development of single-use virus filters is further fueling the market growth. However, high capital investment required for setting up virus filtration facilities remains a key challenge.
Segment Analysis
The global virus filtration market is dominated by the filtration products segment. Within this segment, membrane filters are the largest sub-segment due to their high efficiency in removing viruses from biological drug products and ensuring product safety. Membrane filters provide a reliable means of virus removal with high flow rates and are cost-effective compared to other virus removal methods like chromatography.
PEST Analysis
Political: Government regulations regarding ensuring sterility of drug products from viral contamination is driving increased adoption of virus filtration systems in pharmaceutical and biotechnology companies.
Economic: Rising drug development activities especially in biologics and vaccines has fuelled demand for virus filtration from biopharma and CDMOs who must comply with laid down quality standards.
Social: Increased health awareness and safe healthcare is driving demand for virus-free medicines across male and female population alike which is benefiting virus filtration market.
Technological: Advancements in filtration membrane technologies allowing improved throughput and viral retention abilities at lower costs through new materials is boosting virus filtration system uptake.
Key Takeaways
The Global Virus Filtration Market Size is expected to witness high growth, exhibiting CAGR of 14% over the forecast period, due to increasing biologics drug production. The biologics sub-segment currently dominates the application segment and is expected to grow at a fastest pace due to rising demand for monoclonal antibodies and vaccines.
North America currently dominates the virus filtration market due to presence of majority of leading biopharmaceutical players and stringent regulatory requirements regarding sterility of drug products in the region. Asia Pacific is expected to exhibit fastest growth in the virus filtration market over the forecast period owing to increasing investments by leading players to establish manufacturing units in countries like China and India along with presence of contract manufacturing hubs.
Key players operating in the virus filtration market are Wuxi Biologics, Clean Cell Inc., Sartorius AG, Pall Corporation, Merck KgaA, Lonza Group Ltd., General Electric Company, Thermo Fischer Scientific Inc., Asahi Kasei Medical Co. Ltd., and Charles River Laboratories International Inc., among others. Major players are focused on expanding their membrane filter production capabilities and capabilities through acquisitions and collaborations with CDMOs globally.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it